RLAY · Relay Therapeutics, Inc.

$19.77 +0.07 (+0.36%)

Market Cap

$4.32B

219.14M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-06	—
10-Q	2026-08-06	2026-06-30
Investor Event Transcript	2026-06-30	—
8-K	2026-06-09	—
Investor Event Transcript	2026-06-08	2026-06-30
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-05-21	2026-05-20
Investor Event Transcript	2026-05-19	2026-06-30
8-K	2026-05-19	—
10-Q	2026-05-05	2026-03-31
8-K	2026-05-05	—
DEF 14A	2026-04-28	2026-06-09
8-K	2026-04-27	—
Investor Event Transcript	2026-03-31	—
8-K	2026-03-16	—
8-K	2026-03-11	2026-03-06
8-K	2026-02-26	—
10-K	2026-02-26	2025-12-31
8-K	2026-02-03	—
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	2025-11-04
10-Q	2025-08-07	2025-06-30
8-K	2025-08-07	—
8-K	2025-06-11	2025-06-08
8-K	2025-06-06	—
8-K	2025-06-04	2025-06-03
10-Q	2025-05-05	2025-03-31
8-K	2025-05-05	—
DEF 14A	2025-04-23	2025-06-06
10-K	2025-02-26	2024-12-31
8-K	2025-02-26	—
8-K	2025-01-13	—
8-K	2024-12-11	—
10-Q	2024-11-06	2024-09-30
8-K	2024-11-06	—
8-K	2024-09-11	2024-09-09
8-K	2024-09-09	—
8-K	2024-08-06	—
10-Q	2024-08-06	2024-06-30
8-K	2024-07-16	2024-07-11
8-K	2024-06-06	2024-06-05
8-K	2024-06-03	—
10-Q	2024-05-02	2024-03-31
8-K	2024-05-02	—
DEF 14A	2024-04-23	2024-06-03
10-K	2024-02-22	2023-12-31
8-K	2024-02-22	—
8-K	2024-01-08	—
8-K	2023-11-02	—
10-Q	2023-11-02	2023-09-30

Showing 1–50 of 99 filings

Key facts CIK 1812364 CUSIP 75943R102 13F (30d) 249 filings 243 filers Visit website Investor relations